Stockreport

Translate Bio Announces $47.5 Million Private Placement

Telesis Bio, Inc.  (TBIO) 
PDF LEXINGTON, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new clas [Read more]